Anaphylaxis increases 8-iso-prostaglandin F2alpha release from guinea-pig lung in vitro.

[1]  G. FitzGerald,et al.  Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[2]  H. Seyberth,et al.  Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases. , 1997, The Journal of pharmacology and experimental therapeutics.

[3]  G. Taylor,et al.  Effect of the isoprostanes, 8-iso prostaglandin E2 and 8-iso prostaglandin F2 alpha on the rabbit lung in vivo. , 1997, Prostaglandins.

[4]  J. Lötvall,et al.  8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. , 1997, American journal of respiratory and critical care medicine.

[5]  C. Patrono,et al.  Induction of prostaglandin endoperoxide synthase‐2 in human monocytes associated with cyclo‐oxygenase‐dependent F2‐isoprostane formation , 1996, British journal of pharmacology.

[6]  G. FitzGerald,et al.  Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. , 1996, The Journal of biological chemistry.

[7]  M. Yacoub,et al.  8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. , 1996, American journal of respiratory and critical care medicine.

[8]  C. Patrono,et al.  Effects of the novel anti‐inflammatory compounds, N‐[2‐(cyclohexyloxy)‐4‐nitrophenyl] methanesulphonamide (NS‐398) and 5‐methanesulphonamido‐6‐(2, 4‐difluorothiophenyl)‐1‐indanone (L‐745, 337), on the cyclo‐oxygenase activity of human blood prostaglandin endoperoxide synthases , 1995, British journal of pharmacology.

[9]  G. FitzGerald,et al.  Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. , 1995, The Journal of pharmacology and experimental therapeutics.

[10]  G. FitzGerald,et al.  Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α(*) , 1995, The Journal of Biological Chemistry.

[11]  J. Morrow,et al.  Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. , 1994, The Journal of biological chemistry.

[12]  J. Morrow,et al.  Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. , 1993, The American journal of physiology.

[13]  P. Montuschi,et al.  Effects of vasoactive intestinal polypeptide on antigen‐induced bronchoconstriction and thromboxane release in guinea‐pig lung , 1993, British journal of pharmacology.

[14]  J. Morrow,et al.  Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung. , 1993, Journal of applied physiology.

[15]  J. Morrow,et al.  Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Morrow,et al.  Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. , 1992, The American journal of physiology.

[17]  J. Morrow,et al.  Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. , 1992, The Journal of clinical investigation.

[18]  J. Morrow,et al.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Dollery,et al.  Total profiling by GC/NICIMS of the major cyclo-oxygenase products from antigen and leukotriene-challenged guinea-pig lung. , 1984, Biochemical pharmacology.